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Table 1
(A) sGAG amounts, normalized by DMA content, from human BMSCs cultured in
pellet form in the presence of GM, CM  TGFb3  SMF. The values are mean  SD
normalised to cultures in GM alone. (B) TGFb3 levels in supermotont from BMSCs
cultured in GM alone and CM-TGFb3SMF. Values obtained for TGFb3 levels in
culture media alone were subtracted from values obtained from test conditions. *
p<0. 05 compared with GM alone; y p<0.05 compared with CM+TGFb3; x p<0.05
compared with CM-TGFb3.
Conditions (A) Relative sGAG/DNA (B) Total TGFb3 (pg/ml)
24 h 48 h
GM alone 1.0 1499315 1619102
GM + SMF 1.070.03 -
CM - TGFb3 1.200.02 281657* 3111120*
CM-TGFb3 +SMF 1.870.10x 433578* 4864193*
CM + TGFb3 2.520.12* -
CM + TGFb3 + SMF 5.900.15* -
Outcomes by Defect Size
Lesion Size (mm2) Group
I <100
Group II
100 to 300
Group III
301 to 400
Group
IV >400
N 123 138 161 138
Lysholm 86.9 87.1 86.5 87.5
Tegner 4.6 4.8 4.8 5.0
Patietn
Satisfaction
7.9 8.1 8.0 8.2
Figure 1. sGAG secretion by adult human BMSC cultured in GM  SB-431542, CM 
TGFb3  SB-431542  0.4T SMF for 2 weeks. *p<0.05 compared with GM alone;
yp<0.05 between conditions with and without SB-431542.
Figure 2. Representative photographs showing intracellular Ca+2 levels due to a 0.4 T
(5MF) in humar BMSCs cultured in GM.
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STIMULATION OF CHONDROGENIC DIFFERENTIATION OF ADULT
HUMAN PRECURSOR CELLS USING STATIC MAGNETIC FIELD AS
A PHYSICAL CUE
H.D. Amin y, M.A. Brady y, J.-P. St-Pierre y, M.M. Stevens y,
D.R. Overby y, C.R. Ethier z. y Imperial Coll., London, United Kingdom;
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Purpose: The treatment of osteoarthritis would beneﬁt from the ability
to regenerate cartilage by stimulating a ‘resident’ stem cell-like pop-
ulation to undergo chondrogenesis. Repair/regeneration of adult tissues
is sensitive to physical cues, inﬂuencing adult progenitor cell differen-
tiation. For example, electromagnetic and static magnetic ﬁelds (SMF)
can stimulate a number of differentiation pathways, including osteo-
genesis; however, the effect of SMF on chondrogenesis of human
precursors has yet not been examined. The aims of the present study
were to examine: (i) the effects of SMF on chondrogenesis of human
bone marrow stromal cells (BMSCs) and cartilage cells (HACs); (ii)
molecular mechanisms involved in this process in vitro.
Methods: BMSCs and HACs (from 3 patients; LONZA) were used to
assess the effects of SMF on chondrogenesis of human precursors in
pellet or in salt leached polycaprolactone (PCL) scaffolds. HAC results
were similar to those of BMSCs and are not shown here. Brieﬂy,
BMSCs were scaled up in serum free growth media (GM; BD Mosaic),
trypsinized and cultured in pellet (0.5x106 cells/pellet in ‘V’ shaped
bottom Falcon tube) or in PCL scaffolds (106 cells/scaffold in 24 well
plates) in GM and chondrogenic media (CM; DMEM-high glucose, 40
mg/ml L-proline, 50 mg/ml ascorbate-2-phosphate, 100 nM dexa-
methasone, ITS, 1% p/s and 10 ng/ml TGFb3)  SMF. Experiments
were carried out as follows: (i) to examine the optimal SMF strength,
rare earth NdFeB magnets (ﬁeld strengths 0.1-0.6Tesla) were ﬁxed
beneath culture vessels at a distance of 3 mm from the cells. After 3
weeks, the sulphated glycosaminoglycan content (sGAG) was quan-
tiﬁed; (ii) to examine the effect of SMF on the TGFb3 pathway, cells
were cultured in GM  SMF, CM  TGFb3  SMF for 2 weeks and the
sGAG content was examined. Concurrently, supernatant from cells
exposed to SMF at t¼0 was collected at t¼6, 24 and 48h to assess
TGFb3 levels using ELISA. Further, cells were cultured in GM  SB-
431542 (a TGFb receptor blocker) or CM  TGFb3  SB-431542  SMF
for 2 weeks and sGAG levels were quantiﬁed to assess the functional
relevance of the TGFb3 pathway; (iv) to examine the effect of SMF on
changes in intracellular Ca+2 levels under calcium-free conditions
using the FLOU-4 direct kit (Invitrogen). Statistical analyses were
carried out using one-way ANOVA with Bonferroni corrections in
SPSS18.
Results: BMSCs cultured in CM + TGFb3 in the presence of 0.1 - 0.6T
SMF produced progressively increasing amounts of sGAG (data not
shown), with the highest levels (approximately 4- and 2.5-fold
increases compared with GM and CM+TGFb3, respectively) observed in
the presence of a 0.4T SMF (p<0.05) (Table I). Notably, in the absence of
TGFb3 (+ SMF) a smaller relative increase was observed compared with
CM + TGFb3 + SMF. Further, cells cultured in CM - TGFb3 + SMF
produced signiﬁcantly more TGFb3 compared with cells cultured in
GM alone and CM - TGFb3. Moreover, when TGFb receptors were
blocked using SB-431542, signiﬁcant decreases in sGAG levels were
observed under culture conditions CM  TGFb3 + SMF + SB431342
compared with CM  TGFb  SB-431542 (Fig. 1). Within 20s of expo-
sure to SMF, increases in intracellular Ca+2 were observed (Fig. 2). In
contrast, cultures in the absence of SMF did not exhibit such Ca+2
changes.
Conclusions: 0.4T SMF has the ability to induce chondrogenic differ-
entiation of both BMSCs and HACs. The mechanism of action might
include SMF-mediated modulation of Ca+2 and TGFb signaltransduction pathways. Further investigations of Ca+2 and TGFb-regu-
lated molecular events are warranted to better understand how SMF
can induce cartilage differentiation.211
CHARACTERIZATION OF CARTILAGE REPAIR IN A FOCAL MOUSE
DEFECT MODEL
J. Mak, T. Foniok, D. Rushforth, P.T. Salo, J.F. Dunn, R. Krawetz. Univ. of
Calgary, Calgary, AB, Canada
Purpose: Articular cartilage is often thought to have low/no repair
capability, however, the presence of mesenchymal progenitor cells in
the synovial membrane and synovial ﬂuid, suggest the possibility that
some type of endogenous repair mechanism might exist in vivo. A main
drawback in studying cartilage repair, is that few model systems have
demonstrated ‘validated’ articular cartilage repair/regeneration in vivo.
There are, however, a number of studies documenting cartilage
regeneration in mice, speciﬁcally those from the MRL/MpJ ‘superhealer’
strain. Differences in cartilage repair have been observed betweenMRL/
MpJ and C57BL/6 mice at 6 and 12 weeks after full thickness cartilage
defects were induced. In this study, we sought to use magnetic reso-
nance imaging (MRI) to characterize the earlier stages of the repair
Figure 2. 4 weeks post injury. Safranin-O stain of a) 057 and b) MRL with the
respective Sca-1 IHC on the right.
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identify at what speciﬁc point the healing processes diverge between
the two mice strains.
Methods: Two groups of MRL/MpJ and C57BL/6 male mice (5 weeks of
age; n¼ 6 per time point) were used in the study. A custommade depth
controlled needle (26 gauge) was used to introduce a full thickness
cartilage defect into the femoral groove of the left knee. At 4 and 6
weeks post-surgery, the respective groups were euthanized and the
legs were dissected out and ﬁxed in 10% NBF. Using a 9.4 T magnet and
a quadrature coil, samples underwent ex vivo magnetic resonance
imaging using a RARE sequence (Repetition time ¼ 2000 ms; Echo time
¼ 7.6 ms; FOV ¼1.92; Matrix ¼ 256). After imaging, samples were
decalciﬁed using 10% EDTA, embedded in parafﬁn, and sectioned at 7
um thickness. Sections were then stained with Safranin-O and immu-
nohistochemistry (IHC) was performed using the anti-mouse Ly-6A/E
(also known as Stem Cell Antigen- 1; Sca-1).
Results: MRI scans at 4 weeks showed higher signal intensity at the
cartilage compared to those scanned at 6 weeks (Fig1). There were no
observable differences between strains at each time point. Safranin-O
staining of the C57 sections at the 4 weeks, showed lower proteoglycan
content than the MRL at the same time point. Defects were observable
in C57mice at all time points, but were not observed inMRLmice (Fig2).
However, tissues within the MRL defect were not identical with the
surrounding tissues, in speciﬁc regards to proteoglycan content, matrix
structure, and chondrocyte orientation. Also of interest, it was observed
that Sca-1 positive cells were enriched within the C57 defect, but were
not found within the MRL defect (Fig2).
Conclusion: In this study, we sought to characterize the early stages of
endogenous cartilage repair that occurs in MRL/MpJ mice using both
a non-invasive imaging technique (MRI) and tradition histological
methods. Interestingly, MRI scans revealed that at 4 weeks post injury,
there were no observable differences between C57 and MRL mice,
though the Safranin-O stains did show increased cellularity in MRL
samples at the defect compared to C57. Furthermore, the scarcity of Sca-
1+ cells in MRL samples was surprising as the Safranin-o stains had
revealed the superior healing and increased cellularity of the defect
compared to the C57’s. A possible explanation could be that the
recruitment of Sca-1 cells in the MRL's occurs much earlier than the
time points used in this study. This would explain the lack of Sca-1 cells
as well as the increased cellularity and structural organization at the
defects of the MRL's compared to the C57’s. Future efforts will be
focused on earlier time points than what was used in the present study.Figure 1. Imaging of a) C57 and b) MRL legs 4 weeks post injury as well as the c) C57
and d) MRL legs 6 weeks post injury.212
MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE AND PLASMA
RICH IN GROWTH FACTORS IN DEGENERATIVE JOINT DISSEASE IN
DOGS
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A. Purpose: The aim of this study was to compare the effect of adipose
mesenchymal stem cells (aMSC) (Dog Stem) and Plasma rich in
growth factors (PRGF) (PRGF-Endoret) in the treatment of osteoar-
thritis disease (OA) in dogs.
B. Methods: The study was performed in 50 dogs with elbow, knee or
hip degenerative ostheoartritis (documented by X-Rays and clinical
ﬁndings).
The inclusion criteria was the following, healthy animals weighting
more than 20 kg, with presence of OA in one of these joints.
Animals were randomly assigned to one of these two study groups:
 PRGF: one intraarticular injection (2cc) of autologous PRGF obtained
by Anitua's method. Citrate tubes centrifugates at 460G during 8
minutes (n¼23).
 aMSC: one intraarticular injection (2cc containing 30 millions of
mesenchymal stem cells) of autologous adipose mesenchymal stem
cells obtained by Stem Cells method. The adipose tissue was obtained
by open byopsy and cultivated in Stem Cells Laboratories (Belgium)
(n¼25).
Dogs were evaluated the day before the tratment was applied (basal)
and one, three and six months after intraarticular inﬁltrations. The
primary outcome variable was OA degree (assesed by the Bioarth
Ostheoarthritis Scale: radiographic ﬁndings (mild, moderate or severe),
owners questionnaire for functional limitation (measurement scale:
0 to 23 points) and animal joint movement (measurement scale: 0 to 7
points). Additional measures included the visual analogic scale (VAS),
performed by the owner and the veterinarian to assess pain relief
